EQS-AFR: Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

EQS Preliminary announcement financial reports: Dermapharm Holding SE / Preliminary announcement on the disclosure of financial statements
Dermapharm Holding SE: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]

20.08.2024 / 10:00 CET/CEST
Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Dermapharm Holding SE hereby announces that the following financial reports shall be disclosed:

Report Type: Financial report of the group (half-year/Q2)

Language: German
Date of disclosure: August 27, 2024
Address: https://ir.dermapharm.de/de/investor-relations/#tagline-19857

Language: English
Date of disclosure: August 27, 2024
Address: https://ir.dermapharm.de/en/investor-relations/#tagline-19876


20.08.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

 
End of News EQS News Service

1970107  20.08.2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1970107&application_name=news&site_id=investegate~~~e9270e4b-c9b1-4dcc-bff2-c3a86ce0d3b1
UK 100

Latest directors dealings